BNO at this stage is reporting that current tablets are reaching the level which may be therapeutic giving it now an opportunity to be fully tested in a clinical setting. The clinical evaluation is likely to show the level of benefit anticipated in previous minor studies but this is not completely guaranteed. Current rally was entirely premature and based on misunderstanding of the report. Good things are likely to follow but is takes time.